222 related articles for article (PubMed ID: 16410224)
1. Endostatin down-regulates soluble guanylate cyclase (sGC) in endothelial cells in vivo: influence of endostatin on vascular endothelial growth factor (VEGF) signaling.
Schmidt A; Wenzel D; Thorey I; Werner S; Fleischmann BK; Bloch W
Endothelium; 2005; 12(5-6):251-7. PubMed ID: 16410224
[TBL] [Abstract][Full Text] [Related]
2. Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin.
Urbich C; Reissner A; Chavakis E; Dernbach E; Haendeler J; Fleming I; Zeiher AM; Kaszkin M; Dimmeler S
FASEB J; 2002 May; 16(7):706-8. PubMed ID: 11978735
[TBL] [Abstract][Full Text] [Related]
3. Endostatin influences endothelial morphology via the activated ERK1/2-kinase endothelial morphology and signal transduction.
Schmidt A; Wenzel D; Thorey I; Sasaki T; Hescheler J; Timpl R; Addicks K; Werner S; Fleischmann BK; Bloch W
Microvasc Res; 2006 May; 71(3):152-62. PubMed ID: 16650878
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of vascular endothelial growth factor and integrinbeta3 by endostatin in a mouse model of retinal neovascularization.
Zhang M; Yang Y; Yan M; Zhang J
Exp Eye Res; 2006 Jan; 82(1):74-80. PubMed ID: 16198337
[TBL] [Abstract][Full Text] [Related]
5. Angiopoietin-1 gene transfer improves impaired wound healing in genetically diabetic mice without increasing VEGF expression.
Bitto A; Minutoli L; Galeano MR; Altavilla D; Polito F; Fiumara T; Calò M; Lo Cascio P; Zentilin L; Giacca M; Squadrito F
Clin Sci (Lond); 2008 Jun; 114(12):707-18. PubMed ID: 18078386
[TBL] [Abstract][Full Text] [Related]
6. Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function.
Campbell M; Collery R; McEvoy A; Gardiner TA; Stitt AW; Brankin B
Curr Eye Res; 2006 Dec; 31(12):1033-45. PubMed ID: 17169842
[TBL] [Abstract][Full Text] [Related]
7. Endostatin/collagen XVIII--an inhibitor of angiogenesis--is expressed in cartilage and fibrocartilage.
Pufe T; Petersen WJ; Miosge N; Goldring MB; Mentlein R; Varoga DJ; Tillmann BN
Matrix Biol; 2004 Aug; 23(5):267-76. PubMed ID: 15464359
[TBL] [Abstract][Full Text] [Related]
8. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
9. Endothelial endostatin release is induced by general cell stress and modulated by the nitric oxide/cGMP pathway.
Deininger MH; Wybranietz WA; Graepler FT; Lauer UM; Meyermann R; Schluesener HJ
FASEB J; 2003 Jul; 17(10):1267-76. PubMed ID: 12832291
[TBL] [Abstract][Full Text] [Related]
10. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
Morbidelli L; Donnini S; Chillemi F; Giachetti A; Ziche M
Clin Cancer Res; 2003 Nov; 9(14):5358-69. PubMed ID: 14614021
[TBL] [Abstract][Full Text] [Related]
11. FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1.
Hayashi H; Nakagami H; Takami Y; Koriyama H; Mori M; Tamai K; Sun J; Nagao K; Morishita R; Kaneda Y
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):909-14. PubMed ID: 19325137
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of radiation effects by pXLG-mEndo in a lung carcinoma model.
Luo X; Slater JM; Gridley DS
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):553-64. PubMed ID: 15964154
[TBL] [Abstract][Full Text] [Related]
13. Topical vascular endothelial growth factor reverses delayed wound healing secondary to angiogenesis inhibitor administration.
Michaels J; Dobryansky M; Galiano RD; Bhatt KA; Ashinoff R; Ceradini DJ; Gurtner GC
Wound Repair Regen; 2005; 13(5):506-12. PubMed ID: 16176459
[TBL] [Abstract][Full Text] [Related]
14. Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endothelium.
Brankin B; Campbell M; Canning P; Gardiner TA; Stitt AW
Exp Eye Res; 2005 Jul; 81(1):22-31. PubMed ID: 15978251
[TBL] [Abstract][Full Text] [Related]
15. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
Mehta VB; Zhou Y; Radulescu A; Besner GE
Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
[TBL] [Abstract][Full Text] [Related]
16. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
[TBL] [Abstract][Full Text] [Related]
17. Prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer.
Beck MT; Chen NY; Franek KJ; Chen WY
Cancer Res; 2003 Jul; 63(13):3598-604. PubMed ID: 12839947
[TBL] [Abstract][Full Text] [Related]
18. A potent antiangiogenic factor, endostatin prevents the development of asthma in a murine model.
Suzaki Y; Hamada K; Sho M; Ito T; Miyamoto K; Akashi S; Kashizuka H; Ikeda N; Nakajima Y; Iwase M; Homma I; Kobzik L; Kimura H
J Allergy Clin Immunol; 2005 Dec; 116(6):1220-7. PubMed ID: 16337449
[TBL] [Abstract][Full Text] [Related]
19. cGMP-dependent and -independent angiogenesis-related properties of nitric oxide.
Pyriochou A; Vassilakopoulos T; Zhou Z; Papapetropoulos A
Life Sci; 2007 Nov; 81(21-22):1549-54. PubMed ID: 17945311
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the cGMP signaling pathway by melatonin in pancreatic beta-cells.
Stumpf I; Bazwinsky I; Peschke E
J Pineal Res; 2009 Mar; 46(2):140-7. PubMed ID: 19175857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
